93 related articles for article (PubMed ID: 23182687)
1. Use of aspirin post-diagnosis in a cohort of patients with colorectal cancer and its association with all-cause and colorectal cancer specific mortality.
McCowan C; Munro AJ; Donnan PT; Steele RJ
Eur J Cancer; 2013 Mar; 49(5):1049-57. PubMed ID: 23182687
[TBL] [Abstract][Full Text] [Related]
2. The utility of Aspirin in Dukes C and High Risk Dukes B Colorectal cancer--the ASCOLT study: study protocol for a randomized controlled trial.
Ali R; Toh HC; Chia WK;
Trials; 2011 Dec; 12():261. PubMed ID: 22168568
[TBL] [Abstract][Full Text] [Related]
3. Systematic review update of observational studies further supports aspirin role in cancer treatment: Time to share evidence and decision-making with patients?
Elwood PC; Pickering JE; Morgan G; Galante J; Weightman AL; Morris D; Longley M; Mason M; Adams R; Dolwani S; Chia W K J; Lanas A
PLoS One; 2018; 13(9):e0203957. PubMed ID: 30252883
[TBL] [Abstract][Full Text] [Related]
4. Low-dose aspirin and survival from lung cancer: a population-based cohort study.
Mc Menamin ÚC; Cardwell CR; Hughes CM; Murray LM
BMC Cancer; 2015 Nov; 15():911. PubMed ID: 26573580
[TBL] [Abstract][Full Text] [Related]
5. Variation in colorectal cancer treatment and outcomes in Scotland: real world evidence from national linked administrative health data.
Lemmon E; Hanna C; Diernberger K; Paterson HM; Wild SH; Ennis H; Hall PS
Int J Popul Data Sci; 2024; 9(1):2179. PubMed ID: 38476269
[TBL] [Abstract][Full Text] [Related]
6. Acetylsalicylic Acid Effect in Colorectal Cancer Taking into Account the Role of Tobacco, Alcohol and Excess Weight.
Florensa D; Mateo J; Solsona F; Galván L; Mesas M; Piñol R; Espinosa-Leal L; Godoy P
Int J Environ Res Public Health; 2023 Feb; 20(5):. PubMed ID: 36901115
[TBL] [Abstract][Full Text] [Related]
7. Non-steroidal anti-inflammatory drugs and cancer risk in women: results from the Women's Health Initiative.
Brasky TM; Liu J; White E; Peters U; Potter JD; Walter RB; Baik CS; Lane DS; Manson JE; Vitolins MZ; Allison MA; Tang JY; Wactawski-Wende J
Int J Cancer; 2014 Oct; 135(8):1869-83. PubMed ID: 24599876
[TBL] [Abstract][Full Text] [Related]
8. Incident cancer risk after the start of aspirin use: results from a Dutch population-based cohort study of low dose aspirin users.
Hollestein LM; van Herk-Sukel MP; Ruiter R; de Vries E; Mathijssen RH; Wiemer EA; Stijnen T; Coebergh JW; Lemmens VE; Herings RM; Stricker BH; Nijsten T
Int J Cancer; 2014 Jul; 135(1):157-65. PubMed ID: 24285345
[TBL] [Abstract][Full Text] [Related]
9. Population-wide Impact of Long-term Use of Aspirin and the Risk for Cancer.
Cao Y; Nishihara R; Wu K; Wang M; Ogino S; Willett WC; Spiegelman D; Fuchs CS; Giovannucci EL; Chan AT
JAMA Oncol; 2016 Jun; 2(6):762-9. PubMed ID: 26940135
[TBL] [Abstract][Full Text] [Related]
10. Can aspirin reduce the risk of colorectal cancer in people with diabetes? A population-based cohort study.
Lin CC; Lai MS; Shau WY
Diabet Med; 2015 Mar; 32(3):324-31. PubMed ID: 25252097
[TBL] [Abstract][Full Text] [Related]
11. Aspirin use and chronic diseases: a cohort study of the elderly.
Paganini-Hill A; Chao A; Ross RK; Henderson BE
BMJ; 1989 Nov; 299(6710):1247-50. PubMed ID: 2513898
[TBL] [Abstract][Full Text] [Related]
12. Aspirin use after diagnosis but not prediagnosis improves established colorectal cancer survival: a meta-analysis.
Li P; Wu H; Zhang H; Shi Y; Xu J; Ye Y; Xia D; Yang J; Cai J; Wu Y
Gut; 2015 Sep; 64(9):1419-25. PubMed ID: 25239119
[TBL] [Abstract][Full Text] [Related]
13. Aspirin and COX-2 inhibitor use in patients with stage III colon cancer.
Ng K; Meyerhardt JA; Chan AT; Sato K; Chan JA; Niedzwiecki D; Saltz LB; Mayer RJ; Benson AB; Schaefer PL; Whittom R; Hantel A; Goldberg RM; Venook AP; Ogino S; Giovannucci EL; Fuchs CS
J Natl Cancer Inst; 2015 Jan; 107(1):345. PubMed ID: 25432409
[TBL] [Abstract][Full Text] [Related]
14. Relationship between aspirin use after diagnosis of colorectal cancer and patient survival: a meta-analysis of observational studies.
Ye XF; Wang J; Shi WT; He J
Br J Cancer; 2014 Nov; 111(11):2172-9. PubMed ID: 25180765
[TBL] [Abstract][Full Text] [Related]
15. Chemoprevention in Lynch syndrome.
Burn J; Mathers JC; Bishop DT
Fam Cancer; 2013 Dec; 12(4):707-18. PubMed ID: 23880960
[TBL] [Abstract][Full Text] [Related]
16. Timing of Aspirin and Other Nonsteroidal Anti-Inflammatory Drug Use Among Patients With Colorectal Cancer in Relation to Tumor Markers and Survival.
Hua X; Phipps AI; Burnett-Hartman AN; Adams SV; Hardikar S; Cohen SA; Kocarnik JM; Ahnen DJ; Lindor NM; Baron JA; Newcomb PA
J Clin Oncol; 2017 Aug; 35(24):2806-2813. PubMed ID: 28617623
[TBL] [Abstract][Full Text] [Related]
17. Post-operative aspirin use and colorectal cancer-specific survival in patients with stage I-III colorectal cancer.
Goh CH; Leong WQ; Chew MH; Pan YS; Tony LK; Chew L; Tan IB; Toh HC; Tang CL; Fu WP; Chia WK
Anticancer Res; 2014 Dec; 34(12):7407-14. PubMed ID: 25503181
[TBL] [Abstract][Full Text] [Related]
18. Expression of HLA class I antigen, aspirin use, and survival after a diagnosis of colon cancer.
Reimers MS; Bastiaannet E; Langley RE; van Eijk R; van Vlierberghe RL; Lemmens VE; van Herk-Sukel MP; van Wezel T; Fodde R; Kuppen PJ; Morreau H; van de Velde CJ; Liefers GJ
JAMA Intern Med; 2014 May; 174(5):732-9. PubMed ID: 24687028
[TBL] [Abstract][Full Text] [Related]
19. Aspirin and the metabolic hallmark of cancer: novel therapeutic opportunities for colorectal cancer.
Hoskin AJ; Holt AK; Legge DN; Collard TJ; Williams AC; Vincent EE
Explor Target Antitumor Ther; 2023; 4(4):600-615. PubMed ID: 37720350
[TBL] [Abstract][Full Text] [Related]
20. Repurposing approved non-oncology drugs for cancer therapy: a comprehensive review of mechanisms, efficacy, and clinical prospects.
Mohi-Ud-Din R; Chawla A; Sharma P; Mir PA; Potoo FH; Reiner Ž; Reiner I; Ateşşahin DA; Sharifi-Rad J; Mir RH; Calina D
Eur J Med Res; 2023 Sep; 28(1):345. PubMed ID: 37710280
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
